SCHEMBL29516151

SCHEMBL29516151

O=C(CCCCCCSC(=O)CCc1ccc(F)cc1)Nc1nc(-c2ccccc2)cs1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 7/20 0.61
▸ HDAC6 Q9UBN7 7/20 0.61
▸ HDAC9 Q9UKV0 6/20 0.61
▸ HDAC2 Q92769 5/20 0.61
▸ HDAC3 O15379 5/20 0.61
▸ HDAC4 P56524 4/20 0.61
▸ HDAC7 Q8WUI4 4/20 0.61
▸ HDAC10 Q969S8 4/20 0.61
▸ HDAC11 Q96DB2 4/20 0.61
▸ HDAC8 Q9BY41 4/20 0.61
▸ HDAC5 Q9UQL6 4/20 0.61
▸ MAPK1 P28482 3/20 0.60
▸ LMNA P02545 2/20 0.60
▸ SMN1; SMN2 Q16637 1/20 0.57
▸ KMT2A Q03164 3/20 0.55
▸ PRKACA P17612 1/20 0.53
▸ ROCK1 Q13464 1/20 0.53
▸ ELOVL1 Q9BW60 1/20 0.52
▸ MEN1 O00255 2/20 0.52
▸ ALDH1A1 P00352 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29516132 0.96 HDAC1 (0.64) HDAC1HDAC6HDAC9HDAC2HDAC3
SCHEMBL24359615 0.93 HDAC1 (0.67) HDAC1HDAC6HDAC9HDAC2HDAC3
SCHEMBL29516076 0.90 HDAC1 (0.62) HDAC1HDAC6HDAC9HDAC2HDAC3
SCHEMBL29516173 0.88 HDAC1 (0.66) HDAC1HDAC6HDAC9HDAC2HDAC3
SCHEMBL29516107 0.88 MEN1 (0.59) HDAC1HDAC6HDAC9HDAC2HDAC3
SCHEMBL29516227 0.88 MAPT (0.66) HDAC1HDAC6HDAC9HDAC2HDAC3
SCHEMBL29515970 0.87 HDAC1 (0.59) HDAC1HDAC6HDAC9HDAC2HDAC3
SCHEMBL29516155 0.87 HDAC1 (0.64) HDAC1HDAC6HDAC9HDAC2HDAC3
SCHEMBL29516174 0.85 HDAC1 (0.57) HDAC1HDAC6HDAC9HDAC2HDAC3
SCHEMBL29516335 0.84 MEN1 (0.61) HDAC1HDAC6HDAC9HDAC2HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022087456-A1 NEW COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2022-04-28 — — WO disclosed
Send feedback